Dipyrithione attenuates oleic acid-induced acute lung injury

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 1, 2011, Pages 74-80

  Huang, Huang ^a   Pan, Yu ^a   Ye, Yin ^a   Gao, Min ^a   Yin, Zhimin ^b   Luo, Lan ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING NORMAL UNIVERSITY   (China)

Author keywords

Acute lung injury (ALI); Cytokine; Dipyrithione (PTS2); Oleic acid (OA); Polymorhponuclear neutrophils (PMNs); Pulmonary permeability

Indexed keywords

DIPYRITHIONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MYELOPEROXIDASE; OLEIC ACID; PYRITHIONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG STRUCTURE; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACUTE LUNG INJURY; ANIMALS; CAPILLARY PERMEABILITY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED ICR; OLEIC ACID; PEROXIDASE; PYRIDINES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79251594388     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.09.008     Document Type: Article

References (47)

1. Lee W.L., Downey G.P. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001, 7:1-7.
2. Ware L.B., Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349.
3. Luh S.P., Chiang C.H. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies. J Zhejiang Univ Sci B 2007, 8:60-69.
4. Windsor A.C., Mullen P.G., Fowler A.A. Acute lung injury: what have we learned from animal models?. Am J Med Sci 1993, 306:111-116.
5. Tasaka S., Hasegawa N., Ishizaka A. Pharmacology of acute lung injury. Pulm Pharmacol Ther 2002, 15:83-95.
6. Bernard G.R., Artigas A., Brigham K.L., Carlet J., Falke K., Hudson L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
7. Rocco P.R., Zin W.A. Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different?. Curr Opin Crit Care 2005, 11:10-17.
8. Syrbu S., Thrall R.S., Smilowitz H.M. Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury. Exp Lung Res 1996, 22:33-49.
9. Schuster D.P. ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994, 149:245-260.
10. Dickey B.F., Thrall R.S., McCormick J.R., Ward P.A. Oleic-acid-induced lung injury in the rat. Failure of indomethacin treatment or complement depletion to ablate lung injury. Am J Pathol 1981, 103:376-383.
11. Bursten S.L., Federighi D.A., Parsons P., Harris W.E., Abraham E., Moore E.E., et al. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. Crit Care Med 1996, 24:1129-1136.
12. Ashbaugh D.G., Uzawa T. Respiratory and hemodynamic changes after injection of free fatty acids. J Surg Res 1968, 8:417-423.
13. Motohiro A., Furukawa T., Yasumoto K., Inokuchi K. Mechanisms involved in acute lung edema induced in dogs by oleic acid. Eur Surg Res 1986, 18:50-57.
14. Eiermann G.J., Dickey B.F., Thrall R.S. Polymorphonuclear leukocyte participate in acute oleic-acid-induced lung injury. Am Rev Respir Dis 1983, 128:845-850.
15. Mastrangelo A.M., Jeitner T.M., Eaton J.W. Oleic acid cell surface expression and activity of CD11b on human neutrophils. J Immunol 1998, 161:4268-4275.
16. Swank D.W., Moore S.B. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin Proc 1989, 64:1118-1132.
17. Dallegri F., Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res 1997, 46:382-391.
18. Mulligan M.S., Wilson G.P., Todd R.F., Smith C.W., Anderson D.C., Varani J., et al. Role of b1, b2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol 1993, 150:2407-2417.
19. Burns A.R., Smith C.W., Walker D.C. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 2003, 83:309-336.
20. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 1994, 84:2068-2101.
21. Strieter R.M., Kunkel S.L., Showell H.J., Remick D.G., Phan S.H., Ward P.A., et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 1989, 243:1467-1469.
22. Opal S.M., Fisher C.J., Dhainaut J.F., Vincent J.L., Brase R., Lowry S.F., et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The interleukin-1 receptor antagonist sepsis investigator group. Crit Care Med 1997, 25:1115-1124.
23. Fisher C.J., Dhainaut J.F., Opal S.M., Pribble J.P., Balk R.A., Slotman G.J., et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra sepsis syndrome study group. JAMA 1994, 271:1836-1843.
24. Fan Y., Chen H., Qiao B., Luo L., Ma H., Li H., et al. Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione. Mol Cells 2007, 23:30-38.
25. Liu Z., Fan Y., Wang Y., Han C., Pan Y., Huang H., et al. Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice. FEBS Lett 2008, 582:1643-1650.
26. Simons R.K., Maier R.V., Chi E.Y. Pulmonary effects of continuous endotoxin infusion in the rat. Circ Shock 1991, 33:233-243.
27. Moitra J., Sammani S., Garcia J.G. Re-evaluation of Evans blue dye as a marker of albumin clearance in murine models of acute lung injury. Transl Res 2007, 150:253-265.
28. Beilman G. Pathogenesis of oleic acid-induced lung injury in the rat: distribution of oleic acid during injury and early endothelial cell changes. Lipids 1995, 30:817-823.
29. Zhu G.F., Sun B., Niu S.F., Cai Y.Y., Lin K., Lindwall R., et al. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 158:437-443.
30. Folkesson H.G., Matthay M.A., Hébert C.A., Broaddus V.C. Acid aspiration induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995, 96:107-116.
31. Fonte D.A., Hausberger F.X. Pulmonary free fatty acids in experimental fat embolism. J Trauma 1971, 11:668-672.
32. Vadasz I., Morty R.E., Kohstall M.G., Olschewski A., Grimminger F., Seeger W., et al. Oleic acid inhibits alveolar fluid reabsorption: a role in acute respiratory distress syndrome?. Am J Respir Crit Care Med 2005, 171:469-479.
33. Golbidi S., Moriuchi H., Yang C., Irikura M., Irie T., Hamasaki N. Preventive effect of phosphoenolpyruvate on hypoxemia induced by oleic acid in guinea pigs. Biol Pharm Bull 2003, 26:336-340.
34. Moriuchi H., Zaha M., Fukumoto T., Yuizono T. Activation of polymorphonuclear leukocytes in oleic acid-induced lung injury. Intensive Care Med 1998, 24:709-715.
35. Ito K., Mizutani A., Kira S., Mori M., Iwasaka H., Noguchi T. Effect of ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes. Injury 2005, 36:387-394.
36. Kunkel S.L., Standiford T., Kasahara K., Strieter R.M. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991, 17:17-23.
37. Van Antwerpen P., Dufrasne F., Lequeux M., Boudjeltia K.Z., Lessgyer I., Babar S., et al. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. Eur J Pharmacol 2007, 570:235-243.
38. Moreland J.G., Bailey G., Nauseef W.M., Weiss J.P. Organism-specific neutrophil-endothelial cell interactions in response to E. coli, Streptococcus pneumoniae, and Staphylococcus aureus. J Immunol 2004, 172:476-532.
39. Novak R., Tuomanen E. Pathogenesis of pneumococcal pneumonia. Semin Respir Infect 1999, 14:209-217.
40. Andonegui G., Bonder C.S., Green F., Mullaly S.C., Zbytnuik L., Raharjo E., et al. Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 2003, 111:1011-1020.
41. Bullard D.C., Qin L., Lorenzo I., Quinlin W.M., Doyle N.A., Bosse R., et al. P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest 1995, 95:1782-1788.
42. Zarbock A., Singbartl K., Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 2006, 116:3211-3219.
43. Pober J.S., Bevilacqua M.P., Mendrick D.L., LaPiere L.A., Fiers W., Gimbrone M.A. Two distinct monokines, interleukin 1 and tumor necrosis factor, independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986, 136:1680-1687.
44. Wellicome S.M., Thornhill M.H., Pitzalis C., Thomas D.S., Lanchbury J.S., Panayi G.S., et al. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-I, or lipopolysaccharide. J Immunol 1990, 144:2558-2565.
45. Xu G.L., Yao L., Rao S.Y., Gong Z.N., Zhang S.Q., Yu S.Q. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. J Ethnopharmacol 2005, 98:177-183.
46. Meduri G.U., Tolley E.A., Chrousos G.P., Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002, 165:983-991.
47. Doose C.A., Szaleniec M., Behrend P., Müller A., Jastorff B. Chromatographic behavior of pyrithiones. J Chromatogr A 2004, 1052:103-110.